UPDATE: Rodman & Renshaw Upgrades Exact Sciences to Market Outperform


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Rodman & Renshaw is out with its report today on Exact Sciences (NASDAQ: EXAS), upgrading EXAS to Market Outperform from Market Perform.In its report, Rodman & Renshaw writes, "We are upgrading Exact Sciences from Market Perform to Market Outperform with an 18-month Target Price of $12/sh. Exact Sciences was one of the best performing stock in the biotech sector over the last two years – rising over 200%. However, during the recent period ofmarket volatility the stock took a disproportionate beating. There was no fundamental reason contributing to the excess decline."Shares of EXAS closed Friday at $6.44.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorUpgradesAnalyst RatingsBiotechnologyHealth CareRodman & Renshaw